<DOC>
	<DOCNO>NCT01477307</DOCNO>
	<brief_summary>In patient NAFLD/NASH , change liver lipid composition function test follow short dietary intervention associate change gut microbiota</brief_summary>
	<brief_title>Dietary Intervention Intestinal Microbiota Non-alcoholic Fatty Liver</brief_title>
	<detailed_description>Study Hypothesis : In patient NAFLD/NASH , change liver lipid composition function test follow short dietary intervention associate change gut microbiota Study period : - Study duration participant : 7-10 week ( 1-4 week screen period , 3 week intervention + 3 week follow-up ) - Expected study completion date : 30.04.2012 Study type : Single arm before-after study Number patient : 20 subject obesity NAFLD / NASH Main criterion inclusion : - Obesity define BMI &gt; 30 - Abnormal liver function test define ALT &gt; 1.5 time upper limit normal - NAFLD present liver biopsy - Age &gt; 18 year , &lt; 60 year Main exclusion criterion : - Inability unwillingness give consent - Parenteral nutrition ongoing dietary intervention - Bulimia - Other know cause chronic liver disease , include hepatitis B C , iron overload , - Use substance know alter intestinal permeability , include alcohol NSAIDs Intervention : The phase 2 EurodietÂ® program use standardized hypo-caloric diet 3-weeks intervention period . The product commercially available prescribe reach 1000 kcal/day . These product offer free charge . Primary Objective : To assess impact dietary intervention relative abundance fecal Bacteroidetes ( express bacteroidetes firmicutes ratio ) patient obesity , abnormal liver function test NAFLD Secondary Objectives : 1 . To compare fecal microbiota patient NAFLD NASH baseline 2 . To assess fecal microbiota change patient NAFLD NASH dietary intervention 3 . To measure liver fat content baseline dietary intervention 4 . To assess change liver function test ultrasensitive CRP , cytokines serum LPS relation change microbiota liver lipid composition 5 . To measure orocecal transit time , index intestinal pullulation , baseline dietary intervention patient NAFLD NASH 6 . To measure intestinal permeability baseline dietary intervention patient NAFLD NASH 7 . To assess body composition change relation change microbiota liver lipid composition Statistical method : Baseline end-of-treatment change bacterial gender subspecies compare use paired-sample Wilcoxon signed-rank test . ANOVA pair t-test comparison change within group . Pearson Spearman test use assess correlation change microbiota change liver fat content , liver function test , CRP , cytokines intestinal pullulation permeability . Sample size : 20 patient NAFLD/NASH study dietary intervention . Assessment end-points : Fecal microbiota analyse 454-Flex metagenomics Ultrasensitive CRP serum LPS change compare baseline Serum cytokine measure ELISA Liver fat content composition measure use MR spectroscopy Small intestinal overgrowth intestinal permeability assess use standard 13C breath test polyethyleneglycol absorption test Body mass composition change assess use bioelectrical impedance analysis Safety : All adverse event record throughout study , compliance GCP ICH E6 national regulation .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>Obesity define BMI &gt; 30 Abnormal liver function test define ALT &gt; 1.5 time upper limit normal NAFLD present liver biopsy Age &gt; 18 year , &lt; 60 year Inability unwillingness give consent Bulimia Other know cause chronic liver disease , include hepatitis B C , iron overload , Use substances know alter intestinal permeability , include alcohol NSAIDs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>obesity</keyword>
	<keyword>non-alcoholic fatty liver disease</keyword>
</DOC>